Loading
LT
Lomond Therapeutics Holdings, Inc. Stock: price and insider trades · United States
Lomond Therapeutics Holdings, Inc.: what insiders have been doing
Lomond Therapeutics Holdings, Inc. has a thin disclosure history in our data (latest filing: 5 November 2024). New filings will appear here as soon as they are published. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Insider Decl.
5
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Last declaration on 5 November 2024
Declarations5 total
75,000 shares0Common StockSEC:0001213900-24-094680:0
3,550,000 shares0Common StockSEC:0001213900-24-094682:0
539,062 shares@ US$3.20100.0% of flowCommon StockSEC:0001213900-24-094664:0
323,916 shares@ US$3.20100.0% of flowCommon StockSEC:0001213900-24-094666:0
323,916 shares@ US$3.20100.0% of flowCommon StockSEC:0001213900-24-094665:0
5 of 5 declarations
About Lomond Therapeutics Holdings, Inc.
Lomond Therapeutics Holdings, Inc. is a company listed on the XNAS market, focused on developing innovative therapies. It specializes in research and development of therapeutic solutions for specific diseases.
